About Benjamin Thompson
Form D filings for CytoViva in 2023 list Benjamin Thompson as director.
Benjamin Thompson first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Benjamin Thompson in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Benjamin Thompson works with at each company, as listed on that company's latest Form D.
CytoViva Inc · Form D, Nov 6, 2023
GS
Gordon Sherman
Director
CP
Charles Pinckney
Director
BC
Byron Cheatham
Executive officer and director
LG
Lawrence Greer
Director
CC
Cary Chandler
Director
SL
Samuel Lawrence
Executive officer and director
JL
John Lawrence
Chief Operating Officer and director